Welcome to our dedicated page for Medtronic SEC filings (Ticker: MDT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The pacemakers, insulin pumps, and neurostimulators that power Medtronic’s reputation live inside millions of patients—and inside hundreds of dense SEC documents. Product recalls, FDA approvals, and global tax disclosures can stretch a single Medtronic annual report beyond 300 pages, leaving many investors asking ‘where do I find the real story?’
StockTitan answers that question the moment a document hits EDGAR. Our platform ingests every Medtronic 10-K, 10-Q, 8-K, and Form 4, then deploys AI-powered summaries so Medtronic SEC filings explained simply is more than a promise. Need Medtronic insider trading Form 4 transactions or a heads-up on director buys? Real-time alerts flag Medtronic Form 4 insider transactions real-time as they occur. Prefer big-picture context? AI pulls segment revenue and margin shifts straight from the latest Medtronic quarterly earnings report 10-Q filing and packages them into concise dashboards.
Dig deeper with one click: targeted tags guide you to R&D spend, international tax notes, and safety disclosures inside the Medtronic annual report 10-K simplified. Governance questions? The Medtronic proxy statement executive compensation view highlights pay-for-performance metrics, while Medtronic 8-K material events explained keeps you ahead of recalls or FDA warnings. Whether you’re comparing cash-flow trends, tracking Medtronic executive stock transactions Form 4, or seeking a fast Medtronic earnings report filing analysis, our AI delivers the clarity you need for confident decisions—understanding Medtronic SEC documents with AI has never been easier.
Medtronic plc (MDT) – Form 4 filing: EVP Global Operations & Supply Chain Gregory L. Smith reported an automatic share withholding related to tax obligations on 31 Jul 2025.
- Transaction code F indicates 1,630 ordinary shares were surrendered to cover taxes upon vesting of previously granted restricted stock units.
- Price used for withholding: $90.24 per share.
- Post-transaction ownership: Smith directly holds 71,743 Medtronic ordinary shares.
No derivative security activity was reported. The filing reflects routine tax settlement rather than an open-market buy or sell, leaving the executive’s overall equity stake largely intact.
FAQ
What is the current stock price of Medtronic (MDT)?
What is the market cap of Medtronic (MDT)?
